Express News | Tarsus Pharmaceuticals Inc : BofA Global Research Raises Price Objective to $74 From $68

BreakingsJan 6 21:46

The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

Zacks Dec 26, 2024 22:05

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

Zacks Dec 25, 2024 00:00

Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $65

Futu NewsDec 21, 2024 02:31 · Ratings

Tarsus Pharmaceuticals Insider Lowered Holding By 16% During Last Year

Simply Wall StDec 16, 2024 20:05

Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating

Futu NewsNov 30, 2024 01:31 · Ratings